Long QT Syndrome Multi-Gene Panel, NGS
Cryptococcus Antigen, Serum
Hydrocodone and Metabolites, Urine
RBC Band 3 Protein Reduction in Hereditary Spherocytosis
C1 Esterase Inhibitor, Functional Assay
Septin 9 (SEPT9) Methylation Analysis (Epi proColon, ColoVantage)
Fungitell® ß-D Glucan, Serum
Zinc Finger CCCH-type, RNA Binding Motif and Serine/arginine-rich 2 (ZRSR2) Gene Mutation Analysis
IriSight™ Prenatal Analysis
CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis

LDS
Sign up
Log in

LDS
/Medical Tests
/Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.